Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395341 · ClinicalTrials.gov registry record
The Longitudinal Ovarian Reserve Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 20
- Enrollment target
NCT02395341: Completed study, sponsored by University of Pennsylvania.
NCT02395341 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02395341 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Postmenarchal female cancer patients scheduled to undergo cancer therapy may enroll in this study to assess changes in existing and novel surrogate measures of fertility potential before, during and after chemotherapy. Measures of fertility potential to be tested include ultrasound imaging for antral follicle counts and ovarian volumes, endocrine evaluation, and assessment of oxidative stress.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-05 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02395341
The ClinicalTrials.gov registry entry for NCT02395341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02395341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02395341 about?
NCT02395341 is a clinical study titled "The Longitudinal Ovarian Reserve Study". Postmenarchal female cancer patients scheduled to undergo cancer therapy may enroll in this study to assess changes in existing and novel surrogate measures of fertility potential before, during and after chemotherapy. Measures of fertility potential to be tested include ultrasound imaging for antra...
What is the current status of trial NCT02395341?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-05. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT02395341?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.